0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rheumatoid Arthritis Devices Market Insights, Forecast to 2028
Published Date: March 2022
|
Report Code: QYRE-Auto-23A7794
Home | Market Reports | Health | Health Conditions | Arthritis
Global Rheumatoid Arthritis Devices Market Insights Forecast to 2028

Global Rheumatoid Arthritis Devices Market Insights, Forecast to 2028

Code: QYRE-Auto-23A7794
Report
March 2022
117 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures

Rheumatoid Arthritis Devices Market Forecast - 2028

Due to the COVID-19 pandemic, the global Rheumatoid Arthritis Devices market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Implantable Joint Prostheses accounting for % of the Rheumatoid Arthritis Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Elderly segment is altered to an % CAGR throughout this forecast period.

Rheumatoid Arthritis Devices

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that primarily affects the lining of the synovial joints and is associated with progressive disability, premature death, and socioeconomic burdens.the implantable joint prostheses segment accounted for the largest share of the total rheumatoid arthritis market, whereas the spinal devices segment expected to witness double-digit growth rate in the coming years.

Rheumatoid Arthritis Devices Market Size and Share

China Rheumatoid Arthritis Devices market size is valued at US$ million in 2021, while the US and Europe Rheumatoid Arthritis Devices are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Rheumatoid Arthritis Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Rheumatoid Arthritis Devices include Active Implants LLC, Anika Therapeutics, Inc., Arthrex, Inc., Asahi Kasei Pharma Corporation, B. Braun Melsungen AG, CONMED Corporation, EMulate Therapeutics, Inc. (Nativis, Inc.), Integra Lifesciences Corporation and Johnson & Johnson (DePuy Synthes Inc.), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Rheumatoid Arthritis Devices market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Rheumatoid Arthritis Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment By Type

  • Implantable Joint Prostheses
  • Spinal Devices
  • Other

Segment By Application

  • Elderly
  • Young adults

By Company

  • Active Implants LLC
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • Asahi Kasei Pharma Corporation
  • B. Braun Melsungen AG
  • CONMED Corporation
  • EMulate Therapeutics, Inc. (Nativis, Inc.)
  • Integra Lifesciences Corporation
  • Johnson & Johnson (DePuy Synthes Inc.)
  • Novartis AG
  • RTI Surgical, Inc.
  • Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
  • Setpoint Medical Corporation
  • Smith & Nephew plc (Osiris Therapeutics, Inc.)
  • Stryker Corporation (OrthoSpace Ltd.)
  • UCB Pharma S.A.
  • Zimmer Biomet

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
1 Study Coverage
1.1 Rheumatoid Arthritis Devices Product Introduction
1.2 Market by Type
1.2.1 Global Rheumatoid Arthritis Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Implantable Joint Prostheses
1.2.3 Spinal Devices
1.2.4 Other
1.3 Market by Application
1.3.1 Global Rheumatoid Arthritis Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Elderly
1.3.3 Young adults
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Rheumatoid Arthritis Devices Sales Estimates and Forecasts 2017-2028
2.2 Global Rheumatoid Arthritis Devices Revenue Estimates and Forecasts 2017-2028
2.3 Global Rheumatoid Arthritis Devices Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Rheumatoid Arthritis Devices Sales by Region
2.4.1 Global Rheumatoid Arthritis Devices Sales by Region (2017-2022)
2.4.2 Global Sales Rheumatoid Arthritis Devices by Region (2023-2028)
2.5 Global Rheumatoid Arthritis Devices Revenue by Region
2.5.1 Global Rheumatoid Arthritis Devices Revenue by Region (2017-2022)
2.5.2 Global Rheumatoid Arthritis Devices Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Rheumatoid Arthritis Devices Sales by Manufacturers
3.1.1 Global Top Rheumatoid Arthritis Devices Manufacturers by Sales (2017-2022)
3.1.2 Global Rheumatoid Arthritis Devices Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rheumatoid Arthritis Devices in 2021
3.2 Global Rheumatoid Arthritis Devices Revenue by Manufacturers
3.2.1 Global Rheumatoid Arthritis Devices Revenue by Manufacturers (2017-2022)
3.2.2 Global Rheumatoid Arthritis Devices Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Devices Revenue in 2021
3.3 Global Rheumatoid Arthritis Devices Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Rheumatoid Arthritis Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Rheumatoid Arthritis Devices Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rheumatoid Arthritis Devices Sales by Type
4.1.1 Global Rheumatoid Arthritis Devices Historical Sales by Type (2017-2022)
4.1.2 Global Rheumatoid Arthritis Devices Forecasted Sales by Type (2023-2028)
4.1.3 Global Rheumatoid Arthritis Devices Sales Market Share by Type (2017-2028)
4.2 Global Rheumatoid Arthritis Devices Revenue by Type
4.2.1 Global Rheumatoid Arthritis Devices Historical Revenue by Type (2017-2022)
4.2.2 Global Rheumatoid Arthritis Devices Forecasted Revenue by Type (2023-2028)
4.2.3 Global Rheumatoid Arthritis Devices Revenue Market Share by Type (2017-2028)
4.3 Global Rheumatoid Arthritis Devices Price by Type
4.3.1 Global Rheumatoid Arthritis Devices Price by Type (2017-2022)
4.3.2 Global Rheumatoid Arthritis Devices Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Rheumatoid Arthritis Devices Sales by Application
5.1.1 Global Rheumatoid Arthritis Devices Historical Sales by Application (2017-2022)
5.1.2 Global Rheumatoid Arthritis Devices Forecasted Sales by Application (2023-2028)
5.1.3 Global Rheumatoid Arthritis Devices Sales Market Share by Application (2017-2028)
5.2 Global Rheumatoid Arthritis Devices Revenue by Application
5.2.1 Global Rheumatoid Arthritis Devices Historical Revenue by Application (2017-2022)
5.2.2 Global Rheumatoid Arthritis Devices Forecasted Revenue by Application (2023-2028)
5.2.3 Global Rheumatoid Arthritis Devices Revenue Market Share by Application (2017-2028)
5.3 Global Rheumatoid Arthritis Devices Price by Application
5.3.1 Global Rheumatoid Arthritis Devices Price by Application (2017-2022)
5.3.2 Global Rheumatoid Arthritis Devices Price Forecast by Application (2023-2028)
6 North America
6.1 North America Rheumatoid Arthritis Devices Market Size by Type
6.1.1 North America Rheumatoid Arthritis Devices Sales by Type (2017-2028)
6.1.2 North America Rheumatoid Arthritis Devices Revenue by Type (2017-2028)
6.2 North America Rheumatoid Arthritis Devices Market Size by Application
6.2.1 North America Rheumatoid Arthritis Devices Sales by Application (2017-2028)
6.2.2 North America Rheumatoid Arthritis Devices Revenue by Application (2017-2028)
6.3 North America Rheumatoid Arthritis Devices Market Size by Country
6.3.1 North America Rheumatoid Arthritis Devices Sales by Country (2017-2028)
6.3.2 North America Rheumatoid Arthritis Devices Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Rheumatoid Arthritis Devices Market Size by Type
7.1.1 Europe Rheumatoid Arthritis Devices Sales by Type (2017-2028)
7.1.2 Europe Rheumatoid Arthritis Devices Revenue by Type (2017-2028)
7.2 Europe Rheumatoid Arthritis Devices Market Size by Application
7.2.1 Europe Rheumatoid Arthritis Devices Sales by Application (2017-2028)
7.2.2 Europe Rheumatoid Arthritis Devices Revenue by Application (2017-2028)
7.3 Europe Rheumatoid Arthritis Devices Market Size by Country
7.3.1 Europe Rheumatoid Arthritis Devices Sales by Country (2017-2028)
7.3.2 Europe Rheumatoid Arthritis Devices Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Rheumatoid Arthritis Devices Market Size by Type
8.1.1 Asia Pacific Rheumatoid Arthritis Devices Sales by Type (2017-2028)
8.1.2 Asia Pacific Rheumatoid Arthritis Devices Revenue by Type (2017-2028)
8.2 Asia Pacific Rheumatoid Arthritis Devices Market Size by Application
8.2.1 Asia Pacific Rheumatoid Arthritis Devices Sales by Application (2017-2028)
8.2.2 Asia Pacific Rheumatoid Arthritis Devices Revenue by Application (2017-2028)
8.3 Asia Pacific Rheumatoid Arthritis Devices Market Size by Region
8.3.1 Asia Pacific Rheumatoid Arthritis Devices Sales by Region (2017-2028)
8.3.2 Asia Pacific Rheumatoid Arthritis Devices Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Rheumatoid Arthritis Devices Market Size by Type
9.1.1 Latin America Rheumatoid Arthritis Devices Sales by Type (2017-2028)
9.1.2 Latin America Rheumatoid Arthritis Devices Revenue by Type (2017-2028)
9.2 Latin America Rheumatoid Arthritis Devices Market Size by Application
9.2.1 Latin America Rheumatoid Arthritis Devices Sales by Application (2017-2028)
9.2.2 Latin America Rheumatoid Arthritis Devices Revenue by Application (2017-2028)
9.3 Latin America Rheumatoid Arthritis Devices Market Size by Country
9.3.1 Latin America Rheumatoid Arthritis Devices Sales by Country (2017-2028)
9.3.2 Latin America Rheumatoid Arthritis Devices Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Rheumatoid Arthritis Devices Market Size by Type
10.1.1 Middle East and Africa Rheumatoid Arthritis Devices Sales by Type (2017-2028)
10.1.2 Middle East and Africa Rheumatoid Arthritis Devices Revenue by Type (2017-2028)
10.2 Middle East and Africa Rheumatoid Arthritis Devices Market Size by Application
10.2.1 Middle East and Africa Rheumatoid Arthritis Devices Sales by Application (2017-2028)
10.2.2 Middle East and Africa Rheumatoid Arthritis Devices Revenue by Application (2017-2028)
10.3 Middle East and Africa Rheumatoid Arthritis Devices Market Size by Country
10.3.1 Middle East and Africa Rheumatoid Arthritis Devices Sales by Country (2017-2028)
10.3.2 Middle East and Africa Rheumatoid Arthritis Devices Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Active Implants LLC
11.1.1 Active Implants LLC Corporation Information
11.1.2 Active Implants LLC Overview
11.1.3 Active Implants LLC Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Active Implants LLC Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Active Implants LLC Recent Developments
11.2 Anika Therapeutics, Inc.
11.2.1 Anika Therapeutics, Inc. Corporation Information
11.2.2 Anika Therapeutics, Inc. Overview
11.2.3 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Anika Therapeutics, Inc. Recent Developments
11.3 Arthrex, Inc.
11.3.1 Arthrex, Inc. Corporation Information
11.3.2 Arthrex, Inc. Overview
11.3.3 Arthrex, Inc. Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Arthrex, Inc. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Arthrex, Inc. Recent Developments
11.4 Asahi Kasei Pharma Corporation
11.4.1 Asahi Kasei Pharma Corporation Corporation Information
11.4.2 Asahi Kasei Pharma Corporation Overview
11.4.3 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Asahi Kasei Pharma Corporation Recent Developments
11.5 B. Braun Melsungen AG
11.5.1 B. Braun Melsungen AG Corporation Information
11.5.2 B. Braun Melsungen AG Overview
11.5.3 B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 B. Braun Melsungen AG Recent Developments
11.6 CONMED Corporation
11.6.1 CONMED Corporation Corporation Information
11.6.2 CONMED Corporation Overview
11.6.3 CONMED Corporation Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CONMED Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CONMED Corporation Recent Developments
11.7 EMulate Therapeutics, Inc. (Nativis, Inc.)
11.7.1 EMulate Therapeutics, Inc. (Nativis, Inc.) Corporation Information
11.7.2 EMulate Therapeutics, Inc. (Nativis, Inc.) Overview
11.7.3 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 EMulate Therapeutics, Inc. (Nativis, Inc.) Recent Developments
11.8 Integra Lifesciences Corporation
11.8.1 Integra Lifesciences Corporation Corporation Information
11.8.2 Integra Lifesciences Corporation Overview
11.8.3 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Integra Lifesciences Corporation Recent Developments
11.9 Johnson & Johnson (DePuy Synthes Inc.)
11.9.1 Johnson & Johnson (DePuy Synthes Inc.) Corporation Information
11.9.2 Johnson & Johnson (DePuy Synthes Inc.) Overview
11.9.3 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Johnson & Johnson (DePuy Synthes Inc.) Recent Developments
11.10 Novartis AG
11.10.1 Novartis AG Corporation Information
11.10.2 Novartis AG Overview
11.10.3 Novartis AG Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Novartis AG Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis AG Recent Developments
11.11 RTI Surgical, Inc.
11.11.1 RTI Surgical, Inc. Corporation Information
11.11.2 RTI Surgical, Inc. Overview
11.11.3 RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 RTI Surgical, Inc. Recent Developments
11.12 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
11.12.1 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Corporation Information
11.12.2 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Overview
11.12.3 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Recent Developments
11.13 Setpoint Medical Corporation
11.13.1 Setpoint Medical Corporation Corporation Information
11.13.2 Setpoint Medical Corporation Overview
11.13.3 Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Setpoint Medical Corporation Recent Developments
11.14 Smith & Nephew plc (Osiris Therapeutics, Inc.)
11.14.1 Smith & Nephew plc (Osiris Therapeutics, Inc.) Corporation Information
11.14.2 Smith & Nephew plc (Osiris Therapeutics, Inc.) Overview
11.14.3 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Smith & Nephew plc (Osiris Therapeutics, Inc.) Recent Developments
11.15 Stryker Corporation (OrthoSpace Ltd.)
11.15.1 Stryker Corporation (OrthoSpace Ltd.) Corporation Information
11.15.2 Stryker Corporation (OrthoSpace Ltd.) Overview
11.15.3 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Stryker Corporation (OrthoSpace Ltd.) Recent Developments
11.16 UCB Pharma S.A.
11.16.1 UCB Pharma S.A. Corporation Information
11.16.2 UCB Pharma S.A. Overview
11.16.3 UCB Pharma S.A. Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 UCB Pharma S.A. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 UCB Pharma S.A. Recent Developments
11.17 Zimmer Biomet
11.17.1 Zimmer Biomet Corporation Information
11.17.2 Zimmer Biomet Overview
11.17.3 Zimmer Biomet Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Zimmer Biomet Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Zimmer Biomet Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rheumatoid Arthritis Devices Industry Chain Analysis
12.2 Rheumatoid Arthritis Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rheumatoid Arthritis Devices Production Mode & Process
12.4 Rheumatoid Arthritis Devices Sales and Marketing
12.4.1 Rheumatoid Arthritis Devices Sales Channels
12.4.2 Rheumatoid Arthritis Devices Distributors
12.5 Rheumatoid Arthritis Devices Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Rheumatoid Arthritis Devices Industry Trends
13.2 Rheumatoid Arthritis Devices Market Drivers
13.3 Rheumatoid Arthritis Devices Market Challenges
13.4 Rheumatoid Arthritis Devices Market Restraints
14 Key Findings in The Global Rheumatoid Arthritis Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Rheumatoid Arthritis Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Implantable Joint Prostheses
    Table 3. Major Manufacturers of Spinal Devices
    Table 4. Major Manufacturers of Other
    Table 5. Global Rheumatoid Arthritis Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Rheumatoid Arthritis Devices Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Rheumatoid Arthritis Devices Sales by Region (2017-2022) & (K Units)
    Table 8. Global Rheumatoid Arthritis Devices Sales Market Share by Region (2017-2022)
    Table 9. Global Rheumatoid Arthritis Devices Sales by Region (2023-2028) & (K Units)
    Table 10. Global Rheumatoid Arthritis Devices Sales Market Share by Region (2023-2028)
    Table 11. Global Rheumatoid Arthritis Devices Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Rheumatoid Arthritis Devices Revenue Market Share by Region (2017-2022)
    Table 13. Global Rheumatoid Arthritis Devices Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Rheumatoid Arthritis Devices Revenue Market Share by Region (2023-2028)
    Table 15. Global Rheumatoid Arthritis Devices Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Rheumatoid Arthritis Devices Sales Share by Manufacturers (2017-2022)
    Table 17. Global Rheumatoid Arthritis Devices Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Rheumatoid Arthritis Devices Revenue Share by Manufacturers (2017-2022)
    Table 19. Rheumatoid Arthritis Devices Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 20. Global Rheumatoid Arthritis Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Rheumatoid Arthritis Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Devices as of 2021)
    Table 22. Rheumatoid Arthritis Devices Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Rheumatoid Arthritis Devices Product Offered
    Table 24. Date of Manufacturers Enter into Rheumatoid Arthritis Devices Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Rheumatoid Arthritis Devices Sales by Type (2017-2022) & (K Units)
    Table 27. Global Rheumatoid Arthritis Devices Sales by Type (2023-2028) & (K Units)
    Table 28. Global Rheumatoid Arthritis Devices Sales Share by Type (2017-2022)
    Table 29. Global Rheumatoid Arthritis Devices Sales Share by Type (2023-2028)
    Table 30. Global Rheumatoid Arthritis Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Rheumatoid Arthritis Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Rheumatoid Arthritis Devices Revenue Share by Type (2017-2022)
    Table 33. Global Rheumatoid Arthritis Devices Revenue Share by Type (2023-2028)
    Table 34. Rheumatoid Arthritis Devices Price by Type (2017-2022) & (US$/Unit)
    Table 35. Global Rheumatoid Arthritis Devices Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 36. Global Rheumatoid Arthritis Devices Sales by Application (2017-2022) & (K Units)
    Table 37. Global Rheumatoid Arthritis Devices Sales by Application (2023-2028) & (K Units)
    Table 38. Global Rheumatoid Arthritis Devices Sales Share by Application (2017-2022)
    Table 39. Global Rheumatoid Arthritis Devices Sales Share by Application (2023-2028)
    Table 40. Global Rheumatoid Arthritis Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Rheumatoid Arthritis Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Rheumatoid Arthritis Devices Revenue Share by Application (2017-2022)
    Table 43. Global Rheumatoid Arthritis Devices Revenue Share by Application (2023-2028)
    Table 44. Rheumatoid Arthritis Devices Price by Application (2017-2022) & (US$/Unit)
    Table 45. Global Rheumatoid Arthritis Devices Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 46. North America Rheumatoid Arthritis Devices Sales by Type (2017-2022) & (K Units)
    Table 47. North America Rheumatoid Arthritis Devices Sales by Type (2023-2028) & (K Units)
    Table 48. North America Rheumatoid Arthritis Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Rheumatoid Arthritis Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Rheumatoid Arthritis Devices Sales by Application (2017-2022) & (K Units)
    Table 51. North America Rheumatoid Arthritis Devices Sales by Application (2023-2028) & (K Units)
    Table 52. North America Rheumatoid Arthritis Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Rheumatoid Arthritis Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Rheumatoid Arthritis Devices Sales by Country (2017-2022) & (K Units)
    Table 55. North America Rheumatoid Arthritis Devices Sales by Country (2023-2028) & (K Units)
    Table 56. North America Rheumatoid Arthritis Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Rheumatoid Arthritis Devices Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Rheumatoid Arthritis Devices Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Rheumatoid Arthritis Devices Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Rheumatoid Arthritis Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Rheumatoid Arthritis Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Rheumatoid Arthritis Devices Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Rheumatoid Arthritis Devices Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Rheumatoid Arthritis Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Rheumatoid Arthritis Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Rheumatoid Arthritis Devices Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Rheumatoid Arthritis Devices Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Rheumatoid Arthritis Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Rheumatoid Arthritis Devices Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Rheumatoid Arthritis Devices Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Rheumatoid Arthritis Devices Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Rheumatoid Arthritis Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Rheumatoid Arthritis Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Rheumatoid Arthritis Devices Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Rheumatoid Arthritis Devices Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Rheumatoid Arthritis Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Rheumatoid Arthritis Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Rheumatoid Arthritis Devices Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Rheumatoid Arthritis Devices Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Rheumatoid Arthritis Devices Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Rheumatoid Arthritis Devices Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Rheumatoid Arthritis Devices Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Rheumatoid Arthritis Devices Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Rheumatoid Arthritis Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Rheumatoid Arthritis Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Rheumatoid Arthritis Devices Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Rheumatoid Arthritis Devices Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Rheumatoid Arthritis Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Rheumatoid Arthritis Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Rheumatoid Arthritis Devices Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Rheumatoid Arthritis Devices Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Rheumatoid Arthritis Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Rheumatoid Arthritis Devices Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Rheumatoid Arthritis Devices Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Rheumatoid Arthritis Devices Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Rheumatoid Arthritis Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Rheumatoid Arthritis Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Rheumatoid Arthritis Devices Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Rheumatoid Arthritis Devices Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Rheumatoid Arthritis Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Rheumatoid Arthritis Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Rheumatoid Arthritis Devices Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Rheumatoid Arthritis Devices Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Rheumatoid Arthritis Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Rheumatoid Arthritis Devices Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Active Implants LLC Corporation Information
    Table 107. Active Implants LLC Description and Major Businesses
    Table 108. Active Implants LLC Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 109. Active Implants LLC Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Active Implants LLC Recent Developments
    Table 111. Anika Therapeutics, Inc. Corporation Information
    Table 112. Anika Therapeutics, Inc. Description and Major Businesses
    Table 113. Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 114. Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Anika Therapeutics, Inc. Recent Developments
    Table 116. Arthrex, Inc. Corporation Information
    Table 117. Arthrex, Inc. Description and Major Businesses
    Table 118. Arthrex, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 119. Arthrex, Inc. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Arthrex, Inc. Recent Developments
    Table 121. Asahi Kasei Pharma Corporation Corporation Information
    Table 122. Asahi Kasei Pharma Corporation Description and Major Businesses
    Table 123. Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 124. Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Asahi Kasei Pharma Corporation Recent Developments
    Table 126. B. Braun Melsungen AG Corporation Information
    Table 127. B. Braun Melsungen AG Description and Major Businesses
    Table 128. B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 129. B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. B. Braun Melsungen AG Recent Developments
    Table 131. CONMED Corporation Corporation Information
    Table 132. CONMED Corporation Description and Major Businesses
    Table 133. CONMED Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 134. CONMED Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. CONMED Corporation Recent Developments
    Table 136. EMulate Therapeutics, Inc. (Nativis, Inc.) Corporation Information
    Table 137. EMulate Therapeutics, Inc. (Nativis, Inc.) Description and Major Businesses
    Table 138. EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 139. EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. EMulate Therapeutics, Inc. (Nativis, Inc.) Recent Developments
    Table 141. Integra Lifesciences Corporation Corporation Information
    Table 142. Integra Lifesciences Corporation Description and Major Businesses
    Table 143. Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 144. Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Integra Lifesciences Corporation Recent Developments
    Table 146. Johnson & Johnson (DePuy Synthes Inc.) Corporation Information
    Table 147. Johnson & Johnson (DePuy Synthes Inc.) Description and Major Businesses
    Table 148. Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 149. Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Johnson & Johnson (DePuy Synthes Inc.) Recent Developments
    Table 151. Novartis AG Corporation Information
    Table 152. Novartis AG Description and Major Businesses
    Table 153. Novartis AG Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 154. Novartis AG Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Novartis AG Recent Developments
    Table 156. RTI Surgical, Inc. Corporation Information
    Table 157. RTI Surgical, Inc. Description and Major Businesses
    Table 158. RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 159. RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. RTI Surgical, Inc. Recent Developments
    Table 161. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Corporation Information
    Table 162. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Description and Major Businesses
    Table 163. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 164. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Recent Developments
    Table 166. Setpoint Medical Corporation Corporation Information
    Table 167. Setpoint Medical Corporation Description and Major Businesses
    Table 168. Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 169. Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 170. Setpoint Medical Corporation Recent Developments
    Table 171. Smith & Nephew plc (Osiris Therapeutics, Inc.) Corporation Information
    Table 172. Smith & Nephew plc (Osiris Therapeutics, Inc.) Description and Major Businesses
    Table 173. Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 174. Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 175. Smith & Nephew plc (Osiris Therapeutics, Inc.) Recent Developments
    Table 176. Stryker Corporation (OrthoSpace Ltd.) Corporation Information
    Table 177. Stryker Corporation (OrthoSpace Ltd.) Description and Major Businesses
    Table 178. Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 179. Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 180. Stryker Corporation (OrthoSpace Ltd.) Recent Developments
    Table 181. UCB Pharma S.A. Corporation Information
    Table 182. UCB Pharma S.A. Description and Major Businesses
    Table 183. UCB Pharma S.A. Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 184. UCB Pharma S.A. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 185. UCB Pharma S.A. Recent Developments
    Table 186. Zimmer Biomet Corporation Information
    Table 187. Zimmer Biomet Description and Major Businesses
    Table 188. Zimmer Biomet Rheumatoid Arthritis Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 189. Zimmer Biomet Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 190. Zimmer Biomet Recent Developments
    Table 191. Key Raw Materials Lists
    Table 192. Raw Materials Key Suppliers Lists
    Table 193. Rheumatoid Arthritis Devices Distributors List
    Table 194. Rheumatoid Arthritis Devices Customers List
    Table 195. Rheumatoid Arthritis Devices Market Trends
    Table 196. Rheumatoid Arthritis Devices Market Drivers
    Table 197. Rheumatoid Arthritis Devices Market Challenges
    Table 198. Rheumatoid Arthritis Devices Market Restraints
    Table 199. Research Programs/Design for This Report
    Table 200. Key Data Information from Secondary Sources
    Table 201. Key Data Information from Primary Sources
List of Figures
    Figure 1. Rheumatoid Arthritis Devices Product Picture
    Figure 3. Global Rheumatoid Arthritis Devices Market Share by Type in 2021 & 2028
    Figure 3. Implantable Joint Prostheses Product Picture
    Figure 4. Spinal Devices Product Picture
    Figure 5. Other Product Picture
    Figure 6. Global Rheumatoid Arthritis Devices Market Share by Application in 2021 & 2028
    Figure 7. Elderly
    Figure 8. Young adults
    Figure 9. Rheumatoid Arthritis Devices Report Years Considered
    Figure 10. Global Rheumatoid Arthritis Devices Sales 2017-2028 (K Units)
    Figure 11. Global Rheumatoid Arthritis Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Rheumatoid Arthritis Devices Revenue 2017-2028 (US$ Million)
    Figure 13. Global Rheumatoid Arthritis Devices Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Rheumatoid Arthritis Devices Sales Market Share by Region (2017-2022)
    Figure 15. Global Rheumatoid Arthritis Devices Sales Market Share by Region (2023-2028)
    Figure 16. North America Rheumatoid Arthritis Devices Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Rheumatoid Arthritis Devices Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Rheumatoid Arthritis Devices Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Rheumatoid Arthritis Devices Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Rheumatoid Arthritis Devices Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Rheumatoid Arthritis Devices Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Rheumatoid Arthritis Devices Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Rheumatoid Arthritis Devices Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Rheumatoid Arthritis Devices Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Rheumatoid Arthritis Devices Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Rheumatoid Arthritis Devices Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Rheumatoid Arthritis Devices in the World: Market Share by Rheumatoid Arthritis Devices Revenue in 2021
    Figure 28. Global Rheumatoid Arthritis Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Rheumatoid Arthritis Devices Sales Market Share by Type (2017-2028)
    Figure 30. Global Rheumatoid Arthritis Devices Revenue Market Share by Type (2017-2028)
    Figure 31. Global Rheumatoid Arthritis Devices Sales Market Share by Application (2017-2028)
    Figure 32. Global Rheumatoid Arthritis Devices Revenue Market Share by Application (2017-2028)
    Figure 33. North America Rheumatoid Arthritis Devices Sales Market Share by Type (2017-2028)
    Figure 34. North America Rheumatoid Arthritis Devices Revenue Market Share by Type (2017-2028)
    Figure 35. North America Rheumatoid Arthritis Devices Sales Market Share by Application (2017-2028)
    Figure 36. North America Rheumatoid Arthritis Devices Revenue Market Share by Application (2017-2028)
    Figure 37. North America Rheumatoid Arthritis Devices Sales Share by Country (2017-2028)
    Figure 38. North America Rheumatoid Arthritis Devices Revenue Share by Country (2017-2028)
    Figure 39. United States Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Rheumatoid Arthritis Devices Sales Market Share by Type (2017-2028)
    Figure 42. Europe Rheumatoid Arthritis Devices Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Rheumatoid Arthritis Devices Sales Market Share by Application (2017-2028)
    Figure 44. Europe Rheumatoid Arthritis Devices Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Rheumatoid Arthritis Devices Sales Share by Country (2017-2028)
    Figure 46. Europe Rheumatoid Arthritis Devices Revenue Share by Country (2017-2028)
    Figure 47. Germany Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 48. France Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Rheumatoid Arthritis Devices Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Rheumatoid Arthritis Devices Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Rheumatoid Arthritis Devices Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Rheumatoid Arthritis Devices Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Rheumatoid Arthritis Devices Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Rheumatoid Arthritis Devices Revenue Share by Region (2017-2028)
    Figure 58. China Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 61. India Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 63. China Taiwan Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Rheumatoid Arthritis Devices Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Rheumatoid Arthritis Devices Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Rheumatoid Arthritis Devices Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Rheumatoid Arthritis Devices Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Rheumatoid Arthritis Devices Sales Share by Country (2017-2028)
    Figure 72. Latin America Rheumatoid Arthritis Devices Revenue Share by Country (2017-2028)
    Figure 73. Mexico Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Rheumatoid Arthritis Devices Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Rheumatoid Arthritis Devices Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Rheumatoid Arthritis Devices Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Rheumatoid Arthritis Devices Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Rheumatoid Arthritis Devices Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Rheumatoid Arthritis Devices Revenue Share by Country (2017-2028)
    Figure 82. Turkey Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE Rheumatoid Arthritis Devices Revenue (2017-2028) & (US$ Million)
    Figure 85. Rheumatoid Arthritis Devices Value Chain
    Figure 86. Rheumatoid Arthritis Devices Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global and United States Rheumatoid Arthritis and Lupus Treatments Market Report Forecast 2022 2028
Global and United States Rheumatoid Arthritis and Lupus Treatments Market Report & Forecast 2022-2028

Rheumatoid arthritis and lupus belong to a number of autoimmune diseases affecting the musculoskeletal system multisystemic tissue and connective tissues.Market Analysis and Insights Global and United States Rheumatoid Arthritis and Lupus Treatments MarketThis report focuses on global and United States Rheumatoid Arthritis and Lupus Treatments market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Rheumatoid Arthritis and Lupus Treatments market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-24H10250
Tue Apr 05 00:00:00 UTC 2022

Add to Cart

Global and United States Prescription Arthritis Medications Market Report Forecast 2022 2028
Global and United States Prescription Arthritis Medications Market Report & Forecast 2022-2028

Arthritis medicines are generally very effective in helping people with arthritis to manage joint pain and other symptoms.Market Analysis and Insights Global and United States Prescription Arthritis Medications MarketThis report focuses on global and United States Prescription Arthritis Medications market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Prescription Arthritis Medications market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-39T10333
Tue Apr 05 00:00:00 UTC 2022

Add to Cart

Global Rheumatoid Arthritis RA Medications Market Research Report 2022
Global Rheumatoid Arthritis (RA) Medications Market Research Report 2022

Rheumatoid arthritis medications are medications developed for different therapeutic targets of this type of disease.Due to the COVID19 pandemic the global Rheumatoid Arthritis RA Medications market size is estimated to be worth US million in 2021 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the forecast period 20222028.

120 Pages
Type: Report
Code: QYRE-Auto-10C10123
Fri Mar 04 00:00:00 UTC 2022

Add to Cart

Global Rheumatoid Arthritis Devices Market Insights Forecast to 2028
Global Rheumatoid Arthritis Devices Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-23A7794
Thu Mar 03 00:00:00 UTC 2022

Add to Cart